Cardiovascular System
Consists of heart, arteries, veins, capillaries.
Core tasks: deliver O$2$, nutrients, hormones; remove CO$2$, metabolic waste.
Closed-loop, high-pressure circulation; intimately linked to lymphoid system for fluid balance.
Lymphoid System
Plasma → interstitial fluid once it exits blood capillaries.
Lymph capillaries pick up this fluid and convey it to progressively larger lymph vessels (lymphatics) and lymph nodes.
Lymph nodes filter pathogens & present antigens to immune cells.
Septicemia: acute illness due to pathogens or their toxins circulating in blood.
Sepsis: systemic inflammatory response syndrome (SIRS) triggered by infection.
Septic Shock: sepsis + uncontrollable hypotension → multi-organ failure.
Lymphangitis: visibly inflamed lymph vessels; often a diagnostic clue.
Causative agents: Klebsiella spp., Escherichia coli, Pseudomonas aeruginosa.
Lipid A of LPS → massive cytokine release.
Paradox: antibiotics lyse cells, releasing more LPS; treatment focuses on LPS neutralization + cytokine suppression.
Driven by potent exotoxins (e.g., superantigens) rather than LPS.
Typical nosocomial culprits:
Enterococcus faecium, E. faecalis (vancomycin-resistant strains common).
Group B Streptococcus agalactiae → neonatal sepsis.
Can progress to toxic shock syndrome.
Endocarditis – inflammation of endocardium (valves & inner lining).
Pericarditis – inflammation of pericardial sac; classically caused by streptococci.
Myocarditis – inflammation of myocardium (heart muscle) itself.
Etiology: Streptococcus pyogenes (Group A).
Virulence factors: M protein, hyaluronic-acid capsule, streptococcal pyrogenic exotoxins (SPEs).
Transmission: during childbirth → uterine infection → peritonitis.
Autoimmune sequel of untreated S. pyogenes pharyngitis.
Pathology: antibodies vs. streptococcal M protein cross-react with cardiac tissue (molecular mimicry).
Clinical facets:
Carditis (myocarditis, pericarditis, valvular or mural endocarditis).
Subcutaneous nodules, Sydenham’s chorea, erythema marginatum.
Long-term risk: chronic rheumatic heart disease.
Agent: Francisella tularensis (Gram-negative rod).
Transmission: rabbits, deer flies, ticks; also aerosol & lab exposure.
Entry ulcer → regional lymphadenopathy; organism multiplies in macrophages.
Brucella spp. (aerobic Gram-negative coccobacilli).
Reservoirs: cattle, goats, sheep, swine; acquired via unpasteurized milk or animal contact.
Intracellular survival in reticuloendothelial system → periodic («undulant») fever, night sweats, myalgia; rarely fatal.
Bacillus anthracis (Gram-positive, endospore-forming aerobic rod).
Spores in soil, ingested by grazing animals.
Human forms: cutaneous, inhalational, gastrointestinal, injection.
Virulence factors:
Protective antigen (PA) – docks other toxins to host cell.
Edema toxin (EF + PA) – cAMP ↑ → local edema; impairs phagocytes.
Lethal toxin (LF + PA) – metalloprotease that kills macrophages.
Poly-D-glutamic-acid capsule – antiphagocytic, non-immunogenic.
Therapy: ciprofloxacin or doxycycline; livestock vaccination key.
Agent: Clostridium perfringens (Gram-positive, endospore-forming anaerobe).
Grows in ischemic/necrotic tissue → produces exotoxins (e.g., CPA (\alpha\text{-toxin}), CPB (\beta\text{-toxin})) that track along muscle planes.
Clinical: crepitus, myonecrosis, systemic toxemia.
Management: aggressive debridement/amputation + hyperbaric O$_2$.
Bartonella henselae (aerobic Gram-negative) inhabits feline erythrocytes (~50\% of cats).
Papule at scratch site → localized lymphadenitis; usually self-resolving.
Agent: Yersinia pestis (Gram-negative rod).
Vector: rat flea (Xenopsylla\ cheopis).
Flea gut blocked → regurgitates infected blood.
Virulence arsenal: Yops (Yersinia outer proteins) that disable phagocyte signaling; capsule; plasminogen activator.
Clinical forms:
Bubonic – bubo formation; mortality 50–75\% untreated.
Septicemic – bacteria & LPS in blood → shock.
Pneumonic – inhalation/secondary spread; airborne; mortality ~100\% without prompt therapy.
Post-exposure prophylaxis: doxycycline or fluoroquinolone.
Agent: Borrelia burgdorferi (spirochete).
Vector: Ixodes ticks; reservoir: white-footed field mice; deer amplify ticks but are not infected.
Tick life cycle: 2 yrs, 3 blood meals (larva → nymph → adult). Infection acquired at first (mouse) meal → transmitted at second (nymph) meal.
Clinical stages:
Early localized – expanding bull’s-eye (erythema migrans), flu-like symptoms.
Early disseminated – heart block, facial palsy, meningitis, memory deficits.
Late – migrating arthritis due to immune complexes, months–years later.
Diagnosis: ELISA → confirm with Western blot/IFA.
Tx: doxycycline or amoxicillin; IV ceftriaxone for neurologic/cardiac forms.
Agent: Rickettsia rickettsii (obligate intracellular).
Vectors: wood tick (Dermacentor\ andersoni) & dog tick (D. variabilis).
Pathogenesis: invades endothelial cells → escapes phagosome → replicates cytosolically → cell lysis → vascular leak → petechiae, hypotension.
Clinical: fever, severe headache, maculopapular rash incl. palms/soles.
Mortality \approx20\% untreated; doxycycline highly effective if early.
Agent: Dengue virus (DENV 1-4), a Flavivirus.
Vector: Aedes aegypti.
Epidemiology: Caribbean, SE Asia, Latin America, Africa.
Spectrum: asymptomatic → classic dengue (break-bone fever) → DHF/DSS with plasma leakage, hemorrhage, organ failure.
Antibody-dependent enhancement (ADE): heterotypic non-neutralizing Abs from a prior serotype bind FcyR on monocytes → ↑ viral load, ↑ severe disease risk.
No specific antivirals; Dengvaxia licensed for 9–16 y olds with documented previous infection.
Agent: Trypanosoma cruzi (flagellate).
Vector: reduviid (kissing) bug; parasite deposited in feces, rubbed into bite/eye/conjunctiva.
Acute: fever, lymphadenopathy, Romaña’s sign (eyelid swelling).
Chronic (~20–30\%): cardiomyopathy, megacolon, megaesophagus; death from heart failure/arrhythmia.
Agent: Toxoplasma gondii (obligate intracellular).
Life cycle:
Felines shed oocysts (sporulate in 1–5\text{ d}).
Intermediate hosts (rodents, livestock, humans) ingest oocysts → tachyzoites disseminate → bradyzoite cysts in tissues.
Human acquisition: cat litter, gardening, consumption of tissue cysts in undercooked meat.
Major concern: congenital toxoplasmosis if primary maternal infection during pregnancy → stillbirth, hydrocephalus, chorioretinitis.
Agents: Plasmodium spp. — P. vivax (dormant hypnozoites in liver), P. falciparum (cerebral malaria, severe anemia).
Vector: female Anopheles mosquito.
Life cycle highlights:
Sporozoite inoculation → hepatocyte schizogony → merozoites released → cyclic RBC invasion & lysis (36–48 h) producing paroxysms of chills/fever.
Some merozoites → gametocytes → taken up by mosquito to complete cycle.
Global burden: \approx250\text{ million} cases & \approx6\times10^{5} deaths annually.
Key pathology: hemolysis, microvascular sequestration (falciparum), immune activation.
Agents: Schistosoma mansoni, S. haematobium, S. japonicum (blood flukes).
Life cycle: eggs in feces/urine → hatch miracidia → infect snail (intermediate host) → produce fork-tailed cercariae → penetrate human skin → mature in portal circulation → adult pairs reside in mesenteric or vesical veins, laying eggs.
Eggs trapped in tissues → granulomas → intestinal / urinary / hepatic fibrosis.
Distribution: Africa, Middle East, South America, Caribbean.
Endotoxins vs. Exotoxins: Gram-negatives rely on LPS (heat-stable, macrophage cytokine storm); Gram-positives on protein exotoxins (often superantigens).
Vector-borne diseases: Remember arthropod & reservoir pairings (e.g., Ixodes–mice for Lyme, Aedes–human for dengue, Dermacentor–dogs/rodents for RMSF).
Immune-mediated pathology: rheumatic fever (molecular mimicry), dengue (ADE), Lyme arthritis (immune complexes).
Lifecycle questions: be able to sketch Plasmodium, Schistosoma, Toxoplasma, Ixodes tick.
Therapeutic pearls:
Doxycycline covers RMSF, Lyme early, anthrax alternative.
Hyperbaric O$_2$ for gas gangrene; antitoxin not yet widely available.
No antivirals for dengue; vaccine restricted to seropositive children.
Public health: pasteurization (Brucella), livestock vaccination (anthrax), vector control (dengue, malaria), obstetric screening (GBS).
These bullet-style notes capture all slide content plus contextual mechanisms, clinical relevance, and exam-purpose comparisons. Use them as a full replacement for the original 37-slide transcript.